Ushbu ish iqtibos qilgan ishlar

89 ta ish

Ish: Modelling of the Innate and Adaptive Immune Response to SARS Viral Infection, Cytokine Storm and Vaccination

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

   Chaolin Huang, Yeming Wang, Xingwang Li +26

   Maqola202021 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.071145

2. The trinity of COVID-19: immunity, inflammation and intervention

   Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia +2

   Sharh maqola20204 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204770

3. Overview of the immune response

   David Chaplin

   Sharh maqola20103 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204744

4. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

   Jérôme Hadjadj, Nader Yatim, Laura Barnabei +27

   Maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204775

5. Mathematical model of antiviral immune response. I. Data analysis, generalized picture construction and parameters evaluation for hepatitis B

   G. I. Marchuk, Petrov Rv, A. A. Romanyukha +1

   Maqola19912 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204720

6. Viruses and interferon: a fight for supremacy

   Michael G. Katze, Yupeng He, Michael Gale

   Sharh maqola20022 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204740

7. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

   Rudragouda Channappanavar, Stanley Perlman

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204764

8. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

   Sonu Bhaskar, Akansha Sinha, Maciej Banach +6

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204774

9. SARS-CoV-2 viral load is associated with increased disease severity and mortality

   Jesse Fajnzylber, James Regan, Kendyll Coxen +97

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.204779

10. Risk factors for severe and critically ill COVID‐19 patients: A review

    Yadong Gao, Mei Ding, Xiang Dong +17

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204780

11. The ‘cytokine storm’: molecular mechanisms and therapeutic prospects

    Rajendra Karki, Thirumala‐Devi Kanneganti

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204785

12. Innate immunity: the first line of defense against SARS-CoV-2

    Michael Diamond, Thirumala‐Devi Kanneganti

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204793

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204713

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204714

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204715

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204716

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204717

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204718

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204719

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204721

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204722

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204723

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204724

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204725

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204726